Department of Health and Human Services
Food and Drug Administration
- 21 CFR Part 16
- [Docket No. FDA-2024-N-3654]
- RIN 0910-AI97
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Direct final rule; withdrawal.
SUMMARY:
The Food and Drug Administration (FDA or Agency) published in the Federal Register of September 20, 2024, a direct final rule amending the Scope section of our regulation that provides for a regulatory hearing before the Agency. The comment period closed December 4, 2024. FDA is withdrawing the direct final rule because the Agency received significant adverse comment.
DATES:
The direct final rule published at September 20, 2024, 89 FR 77019, is withdrawn effective January 17, 2025.
FOR FURTHER INFORMATION CONTACT:
Robert Schwartz, Center for Tobacco Products, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 1-877-287-1373, CTPRegulations@fda.hhs.gov.